Italy Respiratory Devices Market Size

Italy Respiratory Devices Market Analysis

The Italian respiratory devices market is poised to register a CAGR of 6.8% over the forecast period. The COVID-19 pandemic sparked a rush in the pharmaceutical sector to produce therapeutic and preventive medications. The pandemic favorably impacted the Italian respiratory devices business. According to a study published in the Journal of Respiratory Research in January 2021, COVID- 19 patients had acute respiratory distress syndrome (ARDS), required breathing support, and some had to be hospitalized in the critical care unit (ICU). COVID-19 patients also experienced severe hypoxia with respiratory failure, along with other signs, such as tachypnoea, increased use of accessory muscles, tachycardia, pale and cold periphery, sweating, confusion, agitation, or decreased level of consciousness, and cyanosis. Thus, the demand for respiratory devices significantly increased during the pandemic to provide respiratory support for COVID-19 patients. This positively impacted the growth of the market. Moreover, the market is expected to grow over the forecast period as all COVID-related restrictions have been lifted, and market growth is rebounding by rising respiratory diseases and product launches.

The market for respiratory devices has been growing in Italy due to the increasing prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), TB, Asthma, and sleep apnoea. According to a study published in the National Library of Medicine in March 2022, the CB phenotype was prevalent (48.3%), followed by the E and the A phenotypes (38.8% and 12.8%, respectively). When dyspnoea was the prevailing symptom, the probability of belonging to the COPD-E phenotype was 3.40 times higher. These phenotypes are responsible for the worsening of the COPD . Thus, the increase in the occurrence of the COPD among the Italian population is expected to drive the demand for the respiratory devices over the forecast period.

The country's increasing asthma burden necessitates the use of respiratory devices. According to a study published in the Journal of Asthma in August 2021, the prevalence of asthma in Italy was believed to be around 4%, affecting roughly 2,000,000 persons. Up to 80-90% of patients experience mild-to-moderate asthma each year. Thus, the growing prevalence of respiratory diseases in the country, such as COPD and asthma, are likely to support the growth of the market.

Thus, the aforementioned factors are expected to drive the growth of the market over the forecast period. However, the high cost of devices and instruments might restrain market growth.